Pseudomembranous colitis in a patient treated with paclitaxel for carcinoma of the breast: a case report

Ang, P.; Cheong, W.K.; Khoo, K.S.

Annals of the Academy of Medicine Singapore 29(1): 132-134

2000


ISSN/ISBN: 0304-4602
PMID: 10748982
Document Number: 1864
Introduction: The concomitant antimicrobial properties of antineoplastic agents may play a role in causing pseudomembranous colitis, which has been documented for cisplatin, cyclophosphamide and 5-fluorouracil. Clinical Picture: We describe the first case reported in the English literature of severe pseudomembranous colitis occurring in a patient given paclitaxel as adjuvant chemotherapy for breast cancer. There was no prior antibiotic therapy. Stool culture confirmed Clostridium difficile. Treatment: Oral vancomycin, metronidazole and cholestyramine led to prompt improvement of intestinal symptoms, which resolved in two weeks. Outcome: Repeat colonoscopy performed 3 months later showed total resolution of the colitis. Conclusions: Awareness of pseudomembranous colitis after paclitaxel chemotherapy call avert life-threatening complications.

Document emailed within 1 workday
Secure & encrypted payments

Pseudomembranous colitis in a patient treated with paclitaxel for carcinoma of the breast: a case report